Study shows an increased risk of breast cancer recurrence in postmenopausal patients with obesity and HR+ early-stage breast cancer treated with aromatase inhibitors.
Study shows women who suffered cardiac complications during their first delivery were most at risk for experiencing a second delivery with serious consequences.